Drug Type Small molecule drug |
Synonyms ASC44F |
Target |
Mechanism FAS modulators(Fatty acid synthase modulators), FXR modulators(Bile acid receptor FXR modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Gannex Pharma Co Ltd.Startup |
Active Organization Gannex Pharma Co Ltd.Startup |
Inactive Organization |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | IND Application | CN | Gannex Pharma Co Ltd.Startup | 08 Jul 2022 |